Altimmune, Inc. (ALT) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Altimmune, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.859 Good morning, ladies and gentlemen, and welcome to the Altamune Year-End 2025 Financial 00:00:05.859 -- 00:00:10.846 Results Conference Call. After the speaker's presentation, there will be a question and 00:00:10.846 -- 00:00:15.894 answer session. To ask a question during the session, you will need to press star 1-1 00:00:15.894 -- 00:00:21.762 on your telephone. You will then hear an automated message advising your hand is raised. 00:00:21.762 -- 00:00:26.048 To withdraw your question, please press star 1-1 again. 00:00:26.048 -- 00:00:30.136 As a reminder, this call is being recorded. 00:00:30.136 -- 00:00:35.583 I'll now introduce your host for today's conference call, Lee Roth, President of Burns 00:00:35.583 -- 00:00:39.408 McLellan, Investor Relations Advisor to Altimmune. 00:00:39.408 -- 00:00:40.709 Lee, you may begin. 00:00:40.709 -- 00:00:45.916 Thanks, Gigi, and good morning, everyone. Thank you for joining us for Altimmune's 00:00:45.916 -- 00:00:50.682 fourth quarter 2025 financial results and business update conference call. 00:00:50.682 -- 00:00:54.827 On today's call, you'll hear from Jerry Durso, our Chief Executive Officer, Dr. 00:00:54.827 -- 00:01:00.443 Christoph Arbett-Engels, Chief Medical Officer, Linda Richardson, Chief Commercial Officer, 00:01:00.443 -- 00:01:04.788 and Greg Weaver, Chief Financial Officer. Following management's prepared remarks, we'll 00:01:04.788 -- 00:01:07.752 open the line for the Q&A session. 00:01:07.752 -- 00:01:11.617 Our fourth quarter and full year 2025 earnings release was issued this morning and can 00:01:11.617 -- 00:01:15.662 be found on the investor relations section of the Altamunion website. 00:01:15.662 -- 00:01:19.347 Before we begin, I'd like to remind everyone tha...